In another clinical trial, doxycycline was found to be ineffective in lowering MMP-8 and 9, IL-6, and IL-8 concentrations and in improving lung function parameters; however, it did decrease systemic inflammation in COPD patients [21]. The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.